CEACAM5 and breast cancer: Currently, several specific biomarkers, such as the carcinoembryonic antigen (CEA), carbohydrate antigen 15-3 (CA15-3), progesterone receptor (PR), and estrogen receptor (ER), have been employed extensively to diagnose BC in clinic [6, 7].